Latest Greenwich LifeSciences Inc. (GLSI) News on August 5, 2025
ACCESS Newswire
a month ago
Greenwich LifeSciences Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
GlobeNewswire
4 months ago
Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
MT Newswires
4 months ago
Greenwich LifeSciences Extends Lock-Up Period for Directors, Officers to March 2026
GlobeNewswire
4 months ago
Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026
GlobeNewswire
5 months ago
Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01
Simply Wall St.
5 months ago
55% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is owned by insiders, and they've been buying recently
GlobeNewswire
6 months ago
Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01
Clinical Trials Arena
6 months ago
EMA approves addition of sites to Greenwich LifeSciences’ breast cancer trial
MT Newswires
6 months ago
Greenwich LifeSciences Gets EU Drug Regulator Approval to Add Sites to GLSI-100 Late-Stage Trial
GlobeNewswire
6 months ago
Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe
GlobeNewswire
6 months ago
Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01
GlobeNewswire
7 months ago
Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01
MT Newswires
7 months ago
Greenwich LifeSciences Partners With Unicancer to Activate Sites for Breast Cancer Study in France
GlobeNewswire
7 months ago
Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France
Simply Wall St.
a year ago
Greenwich LifeSciences, Inc. (NASDAQ:GLSI) insiders seem bullish, own 55% and have been buying more recently
GlobeNewswire
a year ago
Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain
GuruFocus.com
a year ago
Insider Buying: CEO and CFO Snehal Patel Acquires Shares of Greenwich LifeSciences Inc (GLSI)
MT Newswires
a year ago
Greenwich Lifesciences Insider Bought Shares Worth $2,499,998, According to a Recent SEC Filing
GlobeNewswire
a year ago
Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025
GuruFocus.com
a year ago
Greenwich LifeSciences Inc (GLSI) CEO and CFO, 10% Owner Snehal Patel Acquires Additional Shares
GlobeNewswire
a year ago
Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators
GlobeNewswire
a year ago
Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
Simply Wall St.
2 years ago